Stocktoria
Fuse Medical, Inc. FZMD
Fuse Medical, Inc. (FZMD) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2022 revenue was $18.6M at a 16.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.6 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Wholesale Trade · percentile among 119 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.07 |
| Retained earnings / assets | -0.127 |
| EBIT / assets | -0.041 |
| Equity / liabilities | -0.015 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| FZMD | Fuse Medical, Inc. | 4/9 | -0.25 | 0.5 | -8.7% |
| ACH | ACCENDRA HEALTH INC/VA/ | 3/9 | -2.59 | — | +3.1% |
| HSIC | HENRY SCHEIN INC | 4/9 | 2.71 | 24.3 | +4% |
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| CAH | CARDINAL HEALTH INC | 7/9 | -0.22 | 32.5 | +14.2% |
| SYY | SYSCO CORP | 5/9 | — | 22.5 | +3.9% |
| PFGC | Performance Food Group Co | 4/9 | 1.92 | 48.3 | +7.2% |
All Wholesale Trade companies →
About Fuse Medical, Inc.
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company provides orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, substitute bone materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Farmers Branch, Texas.
FAQ
Is FZMD financially healthy?
Fuse Medical, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does FZMD pay a dividend?
No, Fuse Medical, Inc. does not currently pay a dividend.
How profitable is FZMD?
In FY2022, Fuse Medical, Inc. had a net margin of 16.6%.
Is FZMD overvalued or undervalued?
Fuse Medical, Inc. trades at about 0.5× trailing earnings — below its 10-year norm (10-year range 1.5×–33.8×, median 15.0×). Stocktoria reports the data, not buy/sell advice.
Is FZMD a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Fuse Medical, Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone, a P/E of about 0.5×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2022-12-31. Facts plus Stocktoria's own computed scores — not investment advice.